IDDF2018-ABS-0113 The safety and tolerability of sof/vel/vox for 8 or 12 weeks in >1,000 patients treated in the polaris-1, polaris-2, polaris-3, and polaris-4 studies: an integrated analysisMichael P Manns,Edward Gane,Bernard E Willems,Stuart K Roberts,Steven Flamm,Marc Bourliere,Tarik Asselah,Laurent Alric,Robert H Hyland,Luisa M Stamm, KC Huang,Diana M Brainard,Chrstina SM Yip, Hai Cheng Huang,Mandana Khalili,Graham R Foster,Stuart C Gordon,K Rajender Reddy,Stefan Zeuzem,Ira M Jacobson,Curtis L Cooper,Alex J Thompson,Kris Kowdley,Eric LawitzClinical Hepatology（2018）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
